Topical Application of Calcium Channel Blockers to Reduce the Progression of Experimentally Induced Myringosclerosis and Tympanosclerosis

Selcuk A., Akdogan O., Ozcan I., Giray S. G., Dere H., Ozogul C.

LARYNGOSCOPE, cilt.118, sa.4, ss.697-705, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 118 Sayı: 4
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1097/mlg.0b013e31815ed115
  • Dergi Adı: LARYNGOSCOPE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.697-705
  • Anahtar Kelimeler: Disease models animals, sclerosis, chronic otitis media, calcium channel blockers, tympanosclerosis, RAT TYMPANIC MEMBRANE, VITAMIN-E TREATMENT, ACUTE OTITIS-MEDIA, ANTAGONISTS, ATHEROSCLEROSIS, PREVENTION, ANTIOXIDANT, INHIBITION, CELLS, MODEL
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objectives: This study aimed to evaluate the ability of topically applied calcium channel blockers (diltiazem) to reduce the progression of experimentally induced myringosclerosis and tympanosclerosis.